The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America

Ann Mullally (Autor)

Buch | Hardcover

2017
Elsevier - Health Sciences Division (Verlag)
978-0-323-53235-8 (ISBN)

Infos

This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!

Produkt-Details

• Erscheinungsdatum: 05.09.2017
• Reihe/Serie: The Clinics: Internal Medicine
• Verlagsort: Philadelphia
• Sprache: englisch
• Maße: 152 x 229 mm
• Gewicht: 410 g
• Themenwelt: Medizinische Fachgebiete ► Innere Medizin ► Hämatologie
• Themenwelt: Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
• ISBN-10: 0-323-53235-7 / 0323532357
• ISBN-13: 978-0-323-53235-8 / 9780323532358
• Zustand: Neuware